Previous 10 | Next 10 |
home / stock / hmtxf / hmtxf news
Calgary, Alberta--(Newsfile Corp. - October 14, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) (" Hemostemix " or the " Company ") is pleased to announce the appointment of Dr. Fraser C. Henderson Sr., MD, as its Chief Medical Officer. Dr. Fraser C. Henderson Sr. is an exception...
Calgary, Alberta--(Newsfile Corp. - October 4, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (" Hemostemix " or the " Company ") is pleased to announce the second in its series of video interviews with ACP-01 recipients taped during August of 2021. With more than 300 patients treated compas...
Calgary, Alberta--(Newsfile Corp. - September 14, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (" Hemostemix " or the " Company ") is pleased to announce the first of a series of video interviews with ACP-01 recipient-patients taped during August of 2021. Treated compassionately with ACP-0...
Calgary, Alberta--(Newsfile Corp. - July 6, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) (" Hemostemix " or the " Company ") is pleased to provide an update on the Phase II Clinical Trial, an update of a decision including a cost award from the Ninth Judicial Ci...
Calgary, Alberta--(Newsfile Corp. - June 21, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) (" Hemostemix " or the " Company ") announced today that, further to its June 11, 2021 news release and pursuant to the closing of the offering of debenture units of the Co...
Calgary, Alberta--(Newsfile Corp. - June 11, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) (" Hemostemix " or the " Company ") is pleased to announce that it closed its previously announced $2,500,000 convertible debenture order from a director of the C...
Calgary, Alberta--(Newsfile Corp. - May 31, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE:2VF0) ("Hemostemix" or the "Company") reminds shareholders that due to COVID-19, its Annual and Special Meeting will be held by Zoom only. Shareholders are invited to the fol...
Calgary, Alberta--(Newsfile Corp. - April 23, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO.F) (" Hemostemix " or the " Company ") is pleased to announce the completion of the Phase II Clinical Trial subject follow up, as the 65 th (final) subject has completed t...
Calgary, Alberta--(Newsfile Corp. - April 8, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0.F) ("Hemostemix" or the "Company") is pleased to announce it is trading on the Frankfurt Stock Exchange under symbol 2VF0.F and it has engaged HE Capital Markets Ltd. (HE Capital) to design...
Calgary, Alberta--(Newsfile Corp. - March 18, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce that it has contracted two additional clinical research associates, is completing the remaining data entry and source document verifications, an...
News, Short Squeeze, Breakout and More Instantly...
Calgary, Alberta--(Newsfile Corp. - June 11, 2024) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it was notified by the World Intellectual Property Organization that it was granted the trademark Your Fountain of Youth by the Swiss Trademark Office. "In four h...
2024-06-03 13:23:23 ET In a press release this morning, %Hemostemix Inc. (TSXV: $HEM) (OTC: $HMTXF) announced it had signed a Letter of Intent ("LOI") with CytoImmune Therapeutics. The LOI will re-establish production of ACP-01 ("ACP") in CytoImmune's state-of-the-art clinical cell manu...
Calgary, Alberta--(Newsfile Corp. - June 3, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) is pleased to announce it has signed a Letter of Intent ("LOI") with CytoImmune Therapuetics ("CytoImmune") to re-establish production of ACP-01 ("ACP") in CytoImmune's state-of-the-art c...